Chen CH et al. |
Comparison of tuberculosis infection rates in a national database of renal transplant patients with data from a single center in Taiwan. |
2014 |
Transplant. Proc. |
pmid:24656019
|
Gaweco AS et al. |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527948
|
Kobayashi M et al. |
HLA-DR matching effect in orthotopic liver transplantation under FK 506. |
1993 |
Transplant. Proc. |
pmid:7679812
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Ueki M et al. |
Peritoneal-omental pouch as a site for islet allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7513462
|
Strasser S et al. |
The effect of FK 506 on canine pancreatic islet cell function in beagle dogs. |
1991 |
Transplant. Proc. |
pmid:1703709
|
Yasunami Y et al. |
Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506. |
1994 |
Transplant. Proc. |
pmid:7513467
|
Urbizu JM et al. |
Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:11959197
|
Furian L et al. |
Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors. |
2014 |
Transplant. Proc. |
pmid:25498057
|
Havrdova T et al. |
Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period. |
2011 |
Transplant. Proc. |
pmid:22099774
|
Gamboa O et al. |
Cost-effectiveness analysis of the early conversion of tacrolimus to mammalian target of rapamycin inhibitors in patients with renal transplantation. |
2011 |
Transplant. Proc. |
pmid:22099798
|
Guitard J et al. |
Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. |
2007 |
Transplant. Proc. |
pmid:17954189
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Gavela MartÃnez E et al. |
Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715913
|
Jain AB et al. |
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. |
1990 |
Transplant. Proc. |
pmid:1689900
|
Fernández A et al. |
Complete switch to everolimus in long-term kidney transplants: evolution of the renal function. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715915
|
Fung JJ et al. |
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. |
1990 |
Transplant. Proc. |
pmid:1689901
|
Ochiai M et al. |
Islet toxicity of FK506 measured in canine autografts. |
1998 |
Transplant. Proc. |
pmid:9532224
|
Pedroso JA et al. |
Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. |
2014 |
Transplant. Proc. |
pmid:25242789
|
Abu-Elmagd KM et al. |
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. |
1991 |
Transplant. Proc. |
pmid:1721272
|
Ericzon BG et al. |
Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721273
|
Stephens J et al. |
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. |
1993 |
Transplant. Proc. |
pmid:7680144
|
Bonet H et al. |
Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. |
1993 |
Transplant. Proc. |
pmid:7680145
|
Chueh SC et al. |
Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. |
2000 |
Transplant. Proc. |
pmid:11120003
|
Vathsala A et al. |
Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs. |
2000 |
Transplant. Proc. |
pmid:11120034
|
Cofan F et al. |
Effect of calcineurin inhibitors on low-density lipoprotein oxidation. |
2005 |
Transplant. Proc. |
pmid:16386540
|
Andereggen E et al. |
Immunohistological study of islet xenograft rejection in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623420
|
Horimoto H et al. |
Hepatocyte xenotransplantation for Nagase's analbuminemic rats: the effect of FK506. |
1996 |
Transplant. Proc. |
pmid:8623421
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
DÃaz-Molina B et al. |
Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation. |
2012 |
Transplant. Proc. |
pmid:23146479
|
Bilodeau JF et al. |
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. |
2009 |
Transplant. Proc. |
pmid:19917367
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
Connelly PR |
Thermodynamics of interaction of FK 506-binding protein and its ligands. |
1991 |
Transplant. Proc. |
pmid:1721304
|
Oppenheimer F |
Steroid withdrawal in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10686314
|
Hohage H et al. |
Cyclosporine and tacrolimus: influence on cardiovascular risk factors. |
2005 |
Transplant. Proc. |
pmid:15848615
|
Yasutomi M et al. |
Mechanism of antibody production in hamster-to-rat concordant xenotransplantation: establishment of a simple model using intravenous injection of concordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518110
|
Schuller S et al. |
Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15848653
|
Mueller AR et al. |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. |
1995 |
Transplant. Proc. |
pmid:7533359
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Telkes G et al. |
Kidney transplantation in hereditary coproporphyria using tacrolimus and mycophenolate mofetil: a case report. |
2013 |
Transplant. Proc. |
pmid:24315002
|
Ebbs A et al. |
Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. |
2002 |
Transplant. Proc. |
pmid:12176404
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Woodle ES et al. |
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721337
|
Weimer R et al. |
sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. |
2005 |
Transplant. Proc. |
pmid:15919463
|
Tanabe M et al. |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. |
1995 |
Transplant. Proc. |
pmid:7533411
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Cakir U et al. |
Role of Everolimus on Cardiac Functions in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28340820
|
Cicero A and Lappin JA |
Pancreas transplantation: experience at University of Texas, Houston. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172339
|
EscartÃn A et al. |
Analysis of pig-MAP after small bowel transplantation in pigs. |
1998 |
Transplant. Proc. |
pmid:9865377
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Zhu Y et al. |
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123011
|
De Paolis P et al. |
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. |
2011 |
Transplant. Proc. |
pmid:21620039
|
Malaise J et al. |
Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182828
|
Meçule A et al. |
Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620040
|
Darras FS et al. |
Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721368
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Todo S et al. |
Clinical small bowel or small bowel plus liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721369
|
Imanishi M et al. |
Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model. |
1994 |
Transplant. Proc. |
pmid:7520615
|
Christians U et al. |
Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. |
1991 |
Transplant. Proc. |
pmid:1703358
|
Boots JM et al. |
Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation? |
2002 |
Transplant. Proc. |
pmid:12493409
|
Peraira JR et al. |
High incidence of severe infections in heart transplant recipients receiving tacrolimus. |
2003 |
Transplant. Proc. |
pmid:12962875
|
Pisitkun T et al. |
The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients. |
2002 |
Transplant. Proc. |
pmid:12493410
|
Okamoto M et al. |
Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center. |
2002 |
Transplant. Proc. |
pmid:12176527
|
Tanabe K et al. |
Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176528
|
Youbin Z et al. |
Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Gene Overexpression Prolongs the Survival of Rat Allogeneic Heart Allografts. |
2015 |
Transplant. Proc. |
pmid:26518962
|
Stratta RJ |
Optimal immunosuppression in pancreas transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083263
|
Rastellini C et al. |
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083278
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Chen YB et al. |
Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population. |
2011 |
Transplant. Proc. |
pmid:21693271
|
Millis JM et al. |
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123421
|
Mollison KW et al. |
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat. |
1996 |
Transplant. Proc. |
pmid:8962236
|
Adams CK and Famili P |
A study of the effects of the drug FK 506 on gingival tissues. |
1991 |
Transplant. Proc. |
pmid:1721405
|
Fukuse T et al. |
Optimal dose of FK 506 in canine lung allotransplantation. |
1992 |
Transplant. Proc. |
pmid:1379757
|
Wada H et al. |
Combination use of suboptimal doses of FK 506 and cyclosporine in canine lung transplantation. |
1992 |
Transplant. Proc. |
pmid:1379758
|
Starzl TE et al. |
Liver transplantation: an unfinished product. |
1989 |
Transplant. Proc. |
pmid:2469232
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Maass E et al. |
Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report. |
2007 |
Transplant. Proc. |
pmid:18089410
|
Uber PA et al. |
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. |
2002 |
Transplant. Proc. |
pmid:12176598
|
Ji SM et al. |
Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results. |
2014 |
Transplant. Proc. |
pmid:25498056
|
Htun YY et al. |
CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients. |
2018 |
Transplant. Proc. |
pmid:29731062
|
Vincenti F |
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267172
|
Lagget M et al. |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. |
1998 |
Transplant. Proc. |
pmid:9723312
|
Ji SM et al. |
Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection. |
2006 |
Transplant. Proc. |
pmid:17175303
|
Ghio L et al. |
Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report. |
2004 |
Transplant. Proc. |
pmid:15251325
|
Ito T et al. |
Bone marrow cell- and FK 506-induced donor-specific unresponsiveness in rat heart allografts. |
1991 |
Transplant. Proc. |
pmid:1721437
|
Ersoy A et al. |
Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15251345
|
DeValeria PA et al. |
FK 506 fails to reverse moderate cardiac allograft rejection in a canine heterotopic model. |
1991 |
Transplant. Proc. |
pmid:1721438
|
Lim SM et al. |
Heterotopic heart transplantation in the rat receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445080
|
Murase N et al. |
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. |
1987 |
Transplant. Proc. |
pmid:2445081
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
González-Pinto I et al. |
Usefulness of the switch to tacrolimus in liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500653
|
Baskiran A et al. |
Pregnancy After Liver Transplantation: Risks and Outcomes. |
2017 |
Transplant. Proc. |
pmid:28923640
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Scholler G et al. |
Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9270822
|
Badiou S et al. |
Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? |
2006 |
Transplant. Proc. |
pmid:16980076
|
Pichlmayr R et al. |
Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. |
1997 |
Transplant. Proc. |
pmid:9270825
|
Fisher A et al. |
Gastrointestinal toxicity associated with FK 506 in liver transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527947
|